The workshop titled “Biobanking. Biosensing. Bioimaging. – How digitalization impacts on the Medical Diagnostics Value Chain” was organised on November 7, 2019, in Linz, Austria at the afo – architekturforum Linz, by the Medical Technology Cluster of Business Upper Austria. The event aimed to establish a cross-border and cross-sector ecosystem that combines digital innovations from the IT sector with three key industries (bioimaging, biosensors and biobanking) in the healthcare sector. Below is a synopsis video from the workshop. Participants from various sectors including diagnostics, IT, biotechnology, bioinformatics, and hybrid were present.
The guest lectures given by Christoph Rampetsreiter (Greiner Bio One International GmbH) and Michael Mayrhofer-Reinhartshuber (KML Vision GmbH) made the participants aware of the extent to which digitisation can improve laboratory processes and the analysis of microscope images. As part of the discussion session, the medical diagnostic value chain was adapted with the participants to enable identification of challenges, strength fields and main working fields.
The main findings reflected that the challenges of medical diagnostics are manifold and above all, decisive for an improved and even more patient-oriented treatment. The digitalisation of quality assurance of patient data and diagnostic products, but also data acquisition, data storage and security are important topics that can be achieved by means of artificial intelligence, deep learning, automation and adaptation to regulations. Project DIGI-B-CUBE offers SMEs the opportunity to meet these challenges and solve them in international cooperation projects.
